Duvakitug outperformed placebo at week 14 in endoscopic response and was well tolerated among patients with moderately to severely active Crohn’s disease, according to research presented at ACG Annual ...
The support is broad to encourage institutions to consider how to address AI-related challenges and opportunities in ways ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback